Horizon Pharma plc Submits Investigational New Drug Application for ACTIMMUNE® in the Treatment of Friedreich's Ataxia
. Marketwired, February 13, 2015
SOURCE: Horizon Pharma plc
Phase 3 Study Expected to Begin in Q2 2015
Friedreich Ataxia and close related scientific news. Topics related to rare diseases.